Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Plan For Generics Pharmacies Estimates Large Cost Savings

This article was originally published in PharmAsia News

Executive Summary

The Indian government's plan to establish a network of retail generics pharmacies around the country is expected to lower the costs of some drugs by as much as 93 percent. A study by the pharmaceutical department shows that by offering an alternative to the traditional ties pharmacies have with drug makers, the cost of drugs to the buyer could be driven lower. A government draft report compares the cost of generics of specific medicines with the branded versions to reach an estimate of the cost savings. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066861

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel